The University of Chicago Header Logo

Connection

James Mitchell to Dopamine Uptake Inhibitors

Back to Details
This is a "connection" page, showing publications James Mitchell has written about Dopamine Uptake Inhibitors.
James Mitchell
Connection Strength
0.110
Dopamine Uptake Inhibitors
  1. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar; 72(3):235-46.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.